Hospital
Boston Medical Center - South Corporation
Boston Medical Center - South Corporation was paid $553K by Medicaid between Oct 2024 and Dec 2024, across 112 billing codes. Its largest line is 99285, emergency room visit (most serious) — 25% of everything it billed.
33Billing provider infoBOSTON MEDICAL CENTER - SOUTH CORPORATION
BROCKTON, MA 02301
BROCKTON, MA 02301
33aNPI1871329110assigned 09/12/2024
33bProvider typeGeneral Acute Care Hospital
28Total paid$553K
24GClaims11,879
24DCodes billed112
24AFirst – last monthOct 2024 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Massachusetts
Rank by total paid#50 of 66
Median peer was paid$29.11M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 11,879 | $553K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 25% | 612 | 558 | $138K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 531 | 506 | $93K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 452 | 438 | $91K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.7% | 173 | 170 | $26K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.2% | 167 | 164 | $23K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 76 | 72 | $12K |
| 59025 | Fetal non-stress test | 2.2% | 36 | 30 | $12K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.1% | 71 | 71 | $11K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.9% | 54 | 54 | $10K |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 444 | 428 | $10K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 314 | 306 | $9K |
| 62323 | 1.3% | 12 | 12 | $7K |
100 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 33 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 616 | $6K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 33 | $5K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 35 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 122 | $5K |
| ATP14 | <1% | 449 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 65 | $5K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 131 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 849 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 84 | $4K |
| 76642 | <1% | 57 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 31 | $3K |
| 76536 | <1% | 41 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 43 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 31 | $2K |
| S9485 | Crisis intervention mental health services, per diem | <1% | 14 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 91 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 72 | $2K |
| 84484 | <1% | 353 | $2K | |
| 71250 | <1% | 20 | $2K | |
| 77062 | <1% | 33 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 16 | $1K |
| 84702 | <1% | 116 | $1K | |
| 72110 | <1% | 40 | $1K | |
| ATP08 | <1% | 138 | $1K | |
| 73562 | <1% | 60 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 79 | $1K |
| 93017 | <1% | 13 | $988.16 | |
| 81025 | <1% | 143 | $903.21 | |
| 83690 | <1% | 143 | $784.32 | |
| 77066 | Tomosynthesis, mammo | <1% | 33 | $740.80 |
| 72100 | <1% | 31 | $697.77 | |
| 73130 | <1% | 35 | $697.76 | |
| 93971 | <1% | 17 | $692.95 | |
| 72131 | <1% | 16 | $686.42 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 106 | $683.52 |
| 73630 | <1% | 33 | $658.99 | |
| 77061 | <1% | 15 | $648.13 | |
| 86850 | <1% | 78 | $629.26 | |
| 77065 | Tomosynthesis, mammo | <1% | 20 | $601.87 |
| 73030 | <1% | 50 | $542.70 | |
| 81001 | <1% | 217 | $534.80 | |
| 71045 | Radiologic examination, chest; single view | <1% | 84 | $527.68 |
| 84703 | <1% | 95 | $523.77 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 43 | $490.30 |
| 80050 | General health panel | <1% | 37 | $458.90 |
| 83880 | <1% | 14 | $450.06 | |
| ATP15 | <1% | 40 | $442.26 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 46 | $440.50 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $433.16 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $433.16 |
| 83735 | <1% | 87 | $419.61 | |
| 87807 | <1% | 38 | $392.70 | |
| 81003 | <1% | 224 | $366.30 | |
| 87081 | <1% | 65 | $333.45 | |
| 73610 | <1% | 39 | $310.12 | |
| 85379 | <1% | 32 | $260.42 | |
| 83605 | <1% | 28 | $244.80 | |
| 86901 | <1% | 81 | $200.64 | |
| 86900 | <1% | 81 | $200.64 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 364 | $169.35 |
| 76801 | <1% | 51 | $160.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 47 | $152.72 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 157 | $152.72 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $148.20 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 62 | $137.90 |
| 85610 | <1% | 42 | $132.30 | |
| 88304 | <1% | 13 | $118.20 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 242 | $107.29 |
| 82947 | <1% | 92 | $100.63 | |
| 87077 | <1% | 17 | $99.82 | |
| 85027 | <1% | 17 | $91.36 | |
| ATP02 | <1% | 15 | $84.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 242 | $75.20 |
| 80053 | Comprehensive metabolic panel | <1% | 599 | $74.48 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 131 | $71.53 |
| 85730 | <1% | 12 | $58.30 | |
| 85652 | <1% | 15 | $23.80 | |
| 82565 | <1% | 32 | $4.52 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 38 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 97 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 41 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 42 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 22 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 146 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 193 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 87 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 13 | $0.00 |
| 88342 | 0% | 17 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 46 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 25 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 14 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 146 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 59 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 23 | $0.00 |
| 80076 | 0% | 30 | $0.00 | |
| 84520 | 0% | 32 | $0.00 | |
| 76376 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBELL, ALASTAIR (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Boston Medical Center - Brighton Corporation | Boston, MA | $467K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.